Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
M. Barata (Almada, Portugal), G. Santos (Almada, Portugal), H. Grumete (Almada, Portugal), M. Lopes (Almada, Portugal), D. Canário (Almada, Portugal), J. Duarte (Almada, Portugal). Predictors of immunotherapy induced immune-related adverse events. 4665

Member's Comments

No comment yet.

Related content which might interest you: How to manage immune-related adverse effects in lung cancer patients under immunotherapy Source: CME Online 2019 Year: 2018 Polymorphisms in genes associated with the development of steroids-induced adverse events Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Management of disease- and therapy-related adverse events Source: ERS Online Course 2019: Essentials of modern lung cancer care – catch up with the latest advances Year: 2019 Frequent adverse events during prolonged Bedaquiline treatment on XDR-tuberculosis patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Adverse anti-tuberculosis drug events and their management Source: Eur Respir Monogr 2018; 82: 205-227 Year: 2018 Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Management of adverse drug events in TB therapy Source: Eur Respir Mon 2012; 58: 167-193 Year: 2012 Risk of serious adverse reactions during the treatment of new tuberculosis patients Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Adverse reactions of tuberculosis treatment in pacients with and without associated digestive disorders Source: Eur Respir J 2003; 22: Suppl. 45, 522s Year: 2003 Adherence to inhaled controller therapy and local adverse events in children with asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Severe adverse effects of antitubercular drugs and patient management Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Accuracy in assessment of acute asthma needs improved to avoid potential adverse outcomes Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Correlation of response to antifibrotic treatment with adverse events to antifibrotic drugs in IPF patients from the real-world EMPIRE registry Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 The relationship between eosinophils and reduction in major adverse cardiac events in ETHOS Source: Virtual Congress 2021 – ALERT: COPD Year: 2021 Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Possible neuropsychic adverse reactions with montelukast in childhood asthma Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001 Adverse events during treatment for latent tuberculosis infection Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016 Year: 2017 Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019